Clinical Trials Related to Chronic Hepatitis Delta

Related studies linked through entity extraction aliases.

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

Status: RECRUITING
Phase: PHASE1/PHASE2

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

Status: WITHDRAWN
Phase: PHASE2

Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta

Status: UNKNOWN
Phase: N/A

Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD)

Status: COMPLETED
Phase: PHASE3

Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

Status: COMPLETED
Phase: PHASE2